Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...
This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.
Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...
Relmada has acquired complete ownership rights to Sepranolone, developed for Tourette syndrome (TS) from Asarina Pharma.
Over 400 enforcement actions, including show cause notices, production stoppages, and license cancellations, have been taken ...
Alys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...
The General Office of the State Council issues the Announcement on the Collection of Clues on the Comprehensive Supervision ...
Vietnam Investment Review on MSN2d
Stimulating year ahead for pharma
Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.
Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...
Yokogawa Electric Corporation has announced the release of OpreX Quality Management System, a product in the OpreX ...
Servier Egypt, a leading player in the pharmaceutical industry and part of the global Servier Group, proudly marked its ...
Learn more about whether Arrowhead Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...